Cardiac Pacemakers, Inc.

Holaira, Inc.

Synecor LLC

Nuvaira, Inc.

Cibiem, Inc.

Other

Emerson Process Management Valve Automation, Inc.

St. Jude Medical Luxembourg Holdings Smi S.a.r.l. (“Sjm Lux Smi”)

Eim Company, Inc.

Spinal Modulation, Inc.

Interventional Autonomics Corporation

Nuxcel2 LLC

Lynn H Elliott

Edwin J Hlavka

William J Linder

Scott R Stubbs

Kenneth Paul Hoyme

Hiten J Doshi

Conrad L Sowder

Richard S Stack

Michael Scott Williams

Daniel Wayne Fifer

Richard Glenn

Geoffrey Orth

Colleen Stack N'diaye

Mir A Imran

Gerald W Scalf

Jason R Lowery

Gary Thomas Seim

Milton M Morris

Jeffrey M Alves

Stephen C Masson

Jeffery M Kramer

April C Pixley

Colleen Stack

Jeyakumar Subbaroyan

Stephen C Masson Jr

Michael S Williams

Colleen Stack N'DIAYE

Neuromodulation of cranial nerves can be used to treat sleep or breathing disorders, among other diseases and disorders. A neuromodulation system can include a housing configured for implantation in an anterior cervical region of a patient, such as at or under a mandible of the patient, such as at least partially in one or more of a submental triangle, a submandibular triangle, and a carotid triangle. The system can include an electrode lead coupled to the housing, and the electrode lead can include an electrode configured to be disposed at or near a cranial nerve target in the patient. The system can be configured to generate electrical neuromodulation signals for delivery to the cranial nerve target using the electrode.

Multiple-lead implantable systems for stimulation of cranial nerves

A method of reducing bronchial constriction in a subject includes delivering energy to create one or more lesions on a main bronchus so as to transect pulmonary nerves sufficiently to reduce bronchial constriction in a lung of the patient distal to the main bronchus.

System and method for bronchial dilation

An implantable neurostimulation (INS) device includes a non-rechargeable battery, a rechargeable battery, an antenna, an inductive coil, a neurostimulation module and a telemetry module. The neurostimulation module produces neurostimulation signals for delivery to target neural tissue, and the telemetry module wirelessly communicates with a non-implantable device using at least one of the antenna and the inductive coil. The non-rechargeable battery provides power to the neurostimulation module, and the rechargeable battery provides power to the telemetry module. The INS device also includes a charge module that charges the rechargeable battery in dependence on signals received from a non-implantable device via the inductive coil. Additional modules, such a sensor module, can be powered by the rechargeable battery. Additionally modules, such as controller, can be powered by the non-rechargeable battery. The rechargeable battery can power components normally powered by the non-rechargeable battery, when a capacity of the non-chargeable battery falls below a threshold.

Implantable neurostimulator devices including both non-rechargeable and rechargeable batteries and methods of use therewith

Systems and methods for treating a patient with dyspnea are disclosed. A method in accordance with a particular embodiment includes identifying the patient as suffering from dyspnea, and, based at least in part on identifying the patient as suffering from dyspnea, implanting an electrical signal delivery element within the patient in signal communication with an afferent neural pathway of a carotid body chemoreceptor. The method can further include at least reducing dyspneic sensations in the patient by directing an electrical signal from the electrical signal delivery element to the neural pathway to at least partially block afferent signals from the chemoreceptor.

Systems and methods for treating dyspnea, including via electrical afferent signal blocking

Methods and systems described herein can be used to automatically turn on and off stimulation of a target dorsal root ganglion (DRG) and/or adjust stimulation parameters. At least one of an input signal (indicative of an electrical field resulting from an electrical signal propagated by adjacent distal sensory nerve fibers toward the target DRG), an output signal (indicative of an electrical field resulting from an electrical signal propagated by adjacent proximal sensory nerve fibers away from the target DRG) or a DRG signal (indicative of an electrical field produced by cell bodies of primary sensory neurons within the target DRG and resulting from an electrical signal propagated by sensory nerve fibers within the target DRG) is/are obtained and analyzed. Delivery of electrical stimulation is turned on and off and/or at least one of pulse amplitude, pulse width and/or pulse repetition rate is/are adjusted based on results of the analysis.

Methods and systems for automatically turning on and off DRG stimulation and adjusting DRG stimulation parameters

An intravascular electrode system includes an expandable anchor and a flexible substrate which carries at least one electrode. The anchor is positioned in a blood vessel and expanded to an expanded position to bias the electrode in contact with the vessel wall. The flexible substrate may be longitudinally withdrawn from its position between the anchor and the vessel wall without removing the anchor from the blood vessel. A second flexible substrate may be longitudinally inserted into position between the anchor and vessel wall as replacement for the first substrate.

Intravascular electrode system and method

Growing community of inventors

Houston, TX, United States of America

Lynn H Elliott